Hot Investor Mandate: Global Technology Firm Invests in Digital and Diagnostic Innovation

13 Dec

A large firm with offices worldwide invests in medical technology companies that are strategically relevant to their business. The firm invests in new technologies via venture investing, incubation, or M&A. The firm invests worldwide.

The firm’s primary focuses within healthcare include diagnostics (particularly point of care diagnostics and molecular diagnostics, patient monitoring, and integrated IoT platforms for health sensors), and digital services (including capacity management, care coordination, technologies that help physicians make diagnoses and other key decisions, and AI technologies in healthcare). The firm will invest in any medical indication area, and only invests in companies that have attained proof of concept data for their product, with a preference for companies that have a product on the market that can demonstrate traction and revenue.

The firm generally does not attach strategic rights to an external investment other than the right to be informed if the company is seeking a buyer. The firm requires a board seat or a board observer in each portfolio company.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: